Keenova Therapeutics plc announced today that it will present a live treatment procedure with XIAFLEX® (collagenase clostridium histolyticum) for Dupuytren's contracture (DC) during the American ...
Analysis to Be Presented at the American Association for Hand Surgery Meeting DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a ...
Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX® (collagenase clostridium histolyticum, or CCH) will be shared at the American ...
MALVERN, Pa., Oct. 15, 2025 /PRNewswire/ -- Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today that a presentation related to Peyronie's disease, or PD, and XIAFLEX ® (collagenase ...
MALVERN, Pa., Oct. 9, 2025 /PRNewswire/ -- Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today that nine presentations related to Peyronie's disease, or PD, and XIAFLEX ® (collagenase ...
Endo is ramping up the next phase of its Dupuytren's contracture marketing drive. Not long after running its first branded ad for Xiaflex in the indication, the drugmaker has dubbed September the ...
A new :90 spot for Xiaflex begins with a couple watching the brand’s groundbreaking 2021 ad, with a carrot substituting for the curved penis of Peyronie’s disease patients. During the commercial, a ...
The 90-second commercial builds on the "Bent Carrot" campaign, launched in 2021, with creative that highlights a couple's journey from diagnosis to treatment. It spotlights the copay program designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback